Cancer News
OncoLink Cancer News - HealthDay


Positive Preclinical Results for Smo Inhibitor in Esophageal CA

Wednesday, December 26, 2012 (Last Updated: 12/27/2012)

WEDNESDAY, Dec. 26 (HealthDay News) -- In rats with induced gastroduodenoesophageal reflux, a small molecular inhibitor of smoothened (Smo) can reduce the risk of developing Barrett's esophagus and esophageal adenocarcinoma, according to a study published online Oct. 26 in the Annals of Surgery.

Noting that activated hedgehog (Hh) pathway correlates with development of Barrett's esophagus and esophageal adenocarcinoma, Michael K. Gibson, M.D., Ph.D., from the University of Pittsburgh, and colleagues examined whether blocking the Hh pathway with the Smo inhibitor could block the development of Barrett's esophagus and esophageal adenocarcinoma in rats with induced gastroduodenoesophageal reflux.

The researchers found that, compared with normal esophageal tissue, mRNA Hh expression was 184 times higher in Barrett's esophagus and 99 times higher in esophageal adenocarcinoma. After 28 weeks, rats treated with an oral Smo inhibitor had relative risk reductions of 36 percent for Barrett's esophagus and 62 percent for esophageal adenocarcinoma. Ki-67 was downregulated in treated versus untreated esophageal adenocarcinoma but there was no difference in cleaved caspase-3.

"In conclusion, we demonstrated that the activated Hh pathway may play an important role in the development of Barrett esophagus and esophageal adenocarcinoma, and the Smo inhibitor has the potential to prevent the development of Barrett esophagus and esophageal adenocarcinoma in the preclinical setting," Gibson and colleagues write. "These preliminary results support the need for a detailed downstream evaluation of the Hh pathway in this model so that we may definitively prove the preventative effect of Smo inhibition and understand the precise mechanism of action."

Abstract
Full Text (subscription or payment may be required)

Specialties OBGYN & Women's Health
Hematology & Oncology
Family Practice
Nursing
Pharmacy

Copyright © 2012 HealthDay. All rights reserved.


I Wish You Knew

Knowledge is Power

View More



Blogs and Web Chats

OncoLink Blogs give our readers a chance to react to and comment on key cancer news topics and provides a forum for OncoLink Experts and readers to share opinions and learn from each other.




OncoLink OncoPilot

Facing a new cancer diagnosis or changing the course of your current treatment? Let our cancer nurses help you through!

Learn More